Routine screening for detection of atrial fibrillation?

Future Cardiology

Volumn 5, Issue 3, 2009, Pages 213-214

  Fitzmaurice, David A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

CEREBROVASCULAR ACCIDENT; EDITORIAL; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; PRIORITY JOURNAL; PULSE RATE; RISK FACTOR; RISK REDUCTION; SCREENING TEST; ADULT; AGED; ATRIAL FIBRILLATION; FEMALE; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH SERVICE; PREVALENCE; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; STATE MEDICINE;

EID: 66949130717     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.3     Document Type: Editorial

References (7)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22, 983-988 (1991)
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG: Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch. Int. Med. 155, 469-473 (1995).
3. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major contributor to stroke in the elderly - the Framingham study. Arch. Int. Med. 147, 1561-1564 (1987).
4. Wilson JMG, Jungner G: The principles and practice of screening for disease. Public Health papers 34, WHO, Geneva, Switzerland (1968).
5. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation; analysis of pooled data from five randomised controlled trials. Arch. Int. Med. 154, 1449-1457 (1994).
6. Fitzmaurice DA, Hobbs FDR, Jowett J et al.: Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 335, 383-386 (2007).
7. Mant J, Hobbs FDR, Fletcher K et al.: Warfarin versus aspirin for stroke prevention in an elderly population with atrial fibrillation (the Birmingham Atrial Fibrillation treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet 370, 493-503 (2007).